Source: http://www.google.es/patents/US7976836?dq=flatulence
Timestamp: 2017-05-27 17:46:33
Document Index: 38172878

Matched Legal Cases: ['Application No. 10183435', 'Application No. 10183252', 'Application No. 10182195', 'Application No. 10182243', 'Application No. 10182362', 'Application No. 10182485', 'Application No. 10183301', 'Application No. 10182433', 'Application No. 10183378', 'Application No. 10182303']

Patente US7976836 - Treatment of stroke using placental stem cells - Google PatentesBúsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »Iniciar sesiónPatentesThe present invention provides a method of extracting and recovering embryonic-like stem cells, including, but not limited to pluripotent or multipotent stem cells, from an exsanguinated human placenta. A placenta is treated to remove residual umbilical cord blood by perfusing an exsanguinated placenta,...http://www.google.es/patents/US7976836?utm_source=gb-gplus-sharePatente US7976836 - Treatment of stroke using placental stem cells Búsqueda avanzada de patentesTry the new Google Patents, with machine-classified Google Scholar results, and Japanese and South Korean patents. Número de publicaciónUS7976836 B2Tipo de publicaciónConcesión Número de solicitudUS 12/341,961 Fecha de publicación12 Jul 2011 Fecha de presentación22 Dic 2008 Fecha de prioridad6 Dic 2000TarifaPagadasTambién publicado comoCA2430989A1, CA2678490A1, EP1349918A1, EP1349918A4, EP1349918B1, EP2206772A2, EP2206772A3, EP2305795A1, EP2322601A1, US7045148, US7638141, US8293223, US8545833, US8580563, US8986984, US9149569, US9387283, US20020123141, US20050272148, US20090053805, US20090142831, US20100120015, US20110217271, US20110217272, US20110223141, US20120020936, US20120058089, US20140349391, US20150175959, US20160289634, WO2002046373A1, WO2002046373A8, WO2002046373A9 Número de publicación12341961, 341961, US 7976836 B2, US 7976836B2, US-B2-7976836, US7976836 B2, US7976836B2 InventoresRobert J. Hariri Cesionario originalAnthrogenesis CorporationExportar citaBiBTeX, EndNote, RefManCitas de patentes (267), Otras citas (192), Citada por (55), Clasificaciones (60), Eventos legales (2) Enlaces externos: USPTO, Cesión de USPTO, EspacenetTreatment of stroke using placental stem cells
US 7976836 B2 Resumen
12. The method of claim 8, wherein said ischemia is a stroke. Descripción
Citas de patentes Patente citada Fecha de presentación Fecha de publicación Solicitante TítuloUS38620023 Jul 196721 Ene 1975Sanfar Lab IncProduction of physiologically active placental substancesUS482900027 May 19869 May 1989The United States Of America As Represented By The Secretary Of The Department Of Health And Human ServicesReconstituted basement membrane complex with biological activityUS500468112 Nov 19872 Abr 1991Biocyte CorporationPreservation of fetal and neonatal hematopoietic stem and progenitor cells of the bloodUS519255310 Nov 19889 Mar 1993Biocyte CorporationIsolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic useUS519798516 Nov 199030 Mar 1993Caplan Arnold IMethod for enhancing the implantation and differentiation of marrow-derived mesenchymal cellsUS522691416 Nov 199013 Jul 1993Caplan Arnold IMethod for treating connective tissue disordersUS527207121 Dic 199021 Dic 1993Applied Research Systems Ars Holding N.V.Method for the modification of the expression characteristics of an endogenous gene of a given cell lineUS535637315 Nov 199118 Oct 1994Miles Inc.Method and apparatus for autologous transfusions in premature infantsUS537258121 Jul 199313 Dic 1994Minneapolis Children's Services CorporationMethod and apparatus for placental blood collectionUS541566526 Ene 199316 May 1995Utah Medical Products, Inc.Umbilical cord clamping, cutting, and blood collecting device and methodUS543799410 Dic 19931 Ago 1995Regents Of The University Of MichiganMethod for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cellsUS546096417 Mar 199324 Oct 1995Regents Of The University Of MinnesotaMethod for culturing hematopoietic cellsUS54647644 Feb 19937 Nov 1995University Of Utah Research FoundationPositive-negative selection methods and vectorsUS54863598 Feb 199423 Ene 1996Osiris Therapeutics, Inc.Human mesenchymal stem cellsUS548799228 Jun 199330 Ene 1996University Of Utah Research FoundationCells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making sameUS55165325 Ago 199414 May 1996Children's Medical Center CorporationInjectable non-immunogenic cartilage and bone preparationUS559162524 Nov 19937 Ene 1997Case Western Reserve UniversityTransduced mesenchymal stem cellsUS56058221 Dic 199425 Feb 1997The Regents Of The University Of MichiganMethods, compositions and devices for growing human hematopoietic cellsUS56270595 Jun 19956 May 1997University Of UtahCells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making sameUS56353862 Nov 19943 Jun 1997The Regents Of The University Of MichiganMethods for regulating the specific lineages of cells produced in a human hematopoietic cell cultureUS56353873 Abr 19953 Jun 1997Cellpro, Inc.Methods and device for culturing human hematopoietic cells and their precursorsUS56437416 Jun 19951 Jul 1997Systemix, Inc.Identification and isolation of human hematopoietic stem cellsUS564604310 Mar 19958 Jul 1997Regents Of The University Of MichiganMethods for the ex vivo replication of human stem cells and/or expansion of human progenitor cellsUS565418626 Feb 19935 Ago 1997The Picower Institute For Medical ResearchBlood-borne mesenchymal cellsUS565438116 Jun 19955 Ago 1997Massachusetts Institute Of TechnologyFunctionalized polyester graft copolymersUS566555714 Nov 19949 Sep 1997Systemix, Inc.Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereofUS566810431 Mar 199316 Sep 1997Toray Industries, Inc.Hematopoietic stem cell growth-promoting compositions containing a fibroblast-derived fragment of fibronectin and a growth factor, and methods employing them in vitro or in vivoUS56701471 Dic 199423 Sep 1997Regents Of The University Of MichiganCompositions containing cultured mitotic human stem cellsUS567035130 Dic 199423 Sep 1997The Regents Of The University Of MichiganMethods and compositions for the ex vivo replication of human hematopoietic stem cellsUS567234615 Jun 199330 Sep 1997Indiana University FoundationHuman stem cell compositions and methodsUS570985430 Abr 199320 Ene 1998Massachusetts Institute Of TechnologyTissue formation by injecting a cell-polymeric solution that gels in vivoUS571661628 Mar 199510 Feb 1998Thomas Jefferson UniversityIsolated stromal cells for treating diseases, disorders or conditions characterized by bone defectsUS571679429 Mar 199610 Feb 1998Xybernaut CorporationCeliac antigenUS57168276 Jun 199510 Feb 1998Systemix, Inc.Human hematopoietic stem cellUS573354121 Abr 199531 Mar 1998The Regent Of The University Of MichiganHematopoietic cells: compositions and methodsUS573354224 Ene 199531 Mar 1998Haynesworth; Stephen E.Enhancing bone marrow engraftment using MSCSUS573639624 Ene 19957 Abr 1998Case Western Reserve UniversityLineage-directed induction of human mesenchymal stem cell differentiationUS57443616 Jun 199528 Abr 1998Indiana UniversityExpansion of human hematopoietic progenitor cells in a liquid mediumUS57503976 Jun 199512 May 1998Systemix, Inc.Human hematopoietic stem cellUS576319725 Jun 19919 Jun 1998Systemix, Inc.Human hematopoietic stem cellUS57632664 Mar 19939 Jun 1998The Regents Of The University Of MichiganMethods, compositions and devices for maintaining and growing human stem and/or hematopoietics cellsUS58076866 Jun 199515 Sep 1998Regents Of University Of MinnesotaPluripotential quiescent stem cell populationUS581109411 Abr 199522 Sep 1998Osiris Therapeutics, Inc.Connective tissue regeneration using human mesenchymal stem cell preparationsUS582773520 May 199627 Oct 1998Morphogen Pharmaceuticals, Inc.Pluripotent mesenchymal stem cells and methods of use thereofUS582774030 Jul 199627 Oct 1998Osiris Therapeutics, Inc.Adipogenic differentiation of human mesenchymal stem cellsUS58277421 Sep 199427 Oct 1998Beth Israel Deaconess Medical Center, Inc.Method of selecting pluripotent hematopioetic progenitor cellsUS58375392 Jun 199517 Nov 1998Osiris Therapeutics, Inc.Monoclonal antibodies for human mesenchymal stem cellsUS58495537 Jun 199515 Dic 1998California Institute Of TechnologyMammalian multipotent neural stem cellsUS585198416 Ago 199622 Dic 1998Genentech, Inc.Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptidesUS585561930 Sep 19965 Ene 1999Case Western Reserve UniversityBiomatrix for soft tissue regenerationUS585878213 Nov 199512 Ene 1999Regents Of The University Of MichiganFunctional human hematopoietic cellsUS586131516 Oct 199619 Ene 1999Amgen Inc.Use of stem cell factor and soluble interleukin-6 receptor for the ex vivo expansion of hematopoietic multipotential cellsUS586641419 Sep 19952 Feb 1999Badylak; Stephen F.Submucosa gel as a growth substrate for cellsUS587430111 Dic 199523 Feb 1999National Jewish Center For Immunology And Respiratory MedicineEmbryonic cell populations and methods to isolate such populationsUS587729916 Jun 19952 Mar 1999Stemcell Technologies Inc.Methods for preparing enriched human hematopoietic cell preparationsUS587931818 Ago 19979 Mar 1999Npbi International B.V.Method of and closed system for collecting and processing umbilical cord bloodUS587994023 May 19979 Mar 1999Fred Hutchinson Cancer Research CenterHuman marrow stromal cell lines which sustain hematopoiesesUS590504128 Jun 199518 May 1999Boehringer Ingelheim International GmbhProcess for preparing and cultivating hematopoietic progenitor cellsUS590693414 Mar 199525 May 1999Morphogen Pharmaceuticals, Inc.Mesenchymal stem cells for cartilage repairUS59087825 Jun 19951 Jun 1999Osiris Therapeutics, Inc.Chemically defined medium for human mesenchymal stem cellsUS590878415 Nov 19961 Jun 1999Case Western Reserve UniversityIn vitro chondrogenic induction of human mesenchymal stem cellsUS59141086 Jun 199522 Jun 1999Systemix, Inc.Human hematopoietic stem cellUS591426821 Nov 199422 Jun 1999National Jewish Center For Immunology & Respiratory MedicineEmbryonic cell populations and methods to isolate such populationsUS591620230 Ago 199629 Jun 1999Haswell; John N.Umbilical cord blood collectionUS591917630 Oct 19966 Jul 1999Children's Hospital Medical Center Of Northern CaliforniaApparatus and method for collecting blood from an umbilical cordUS591970223 Oct 19966 Jul 1999Advanced Tissue Science, Inc.Production of cartilage tissue using cells isolated from Wharton's jellyUS592259713 Nov 199613 Jul 1999Regents Of The University Of MinnesotaEx vivo culture of stem cellsUS59255676 Oct 199720 Jul 1999T. Breeders, Inc.Selective expansion of target cell populationsUS59282143 Ago 199827 Jul 1999New York Blood Center, Inc.High concentration white cells, a method for agglomeration of the high concentration and a bag set for use in conjunction therewithUS59289477 Jun 199527 Jul 1999California Institute Of TechnologyMammalian multipotent neural stem cellsUS594222523 Jul 199724 Ago 1999Case Western Reserve UniversityLineage-directed induction of human mesenchymal stem cell differentiationUS594249630 Sep 199424 Ago 1999The Regent Of The University Of MichiganMethods and compositions for multiple gene transfer into bone cellsUS595876714 Ago 199828 Sep 1999The Children's Medical Center Corp.Engraftable human neural stem cellsUS596232518 Sep 19985 Oct 1999Advanced Tissue Sciences, Inc.Three-dimensional stromal tissue culturesUS59688295 Sep 199719 Oct 1999Cytotherapeutics, Inc.Human CNS neural stem cellsUS596910521 Oct 199719 Oct 1999Feng; YiqingStem cell factor receptor agonistsUS599342914 May 199730 Nov 1999Childen's Hospital Medical Center Of Northern CaliforniaApparatus and method for collecting blood from an umbilical cordUS599786015 Nov 19957 Dic 1999G. D. Searle & Co.Ex-vivo expansion of stem cells using combinations of interleukin-3 (IL-3) variants and other cytokinesUS600165425 Abr 199714 Dic 1999California Institute Of TechnologyMethods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factorsUS601069625 Mar 19984 Ene 2000Osiris Therapeutics, Inc.Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cellsUS60110006 Jun 19954 Ene 2000Perrine; Susan P.Compositions for the treatment of blood disordersUS602046915 Abr 19991 Feb 2000Amgen Inc.Stem cell factor formulations and methodsUS602254028 Ago 19988 Feb 2000Osiris Therapeutics, Inc.Ligands that modulate differentiation of mesenchymal stem cellsUS60227438 Mar 19998 Feb 2000Advanced Tissue Sciences, Inc.Three-dimensional culture of pancreatic parenchymal cells cultured living stromal tissue prepared in vitroUS602284830 Sep 19948 Feb 2000Pro-Neuron, Inc.Inhibitor of stem cell proliferation and uses thereofUS60308368 Jun 199929 Feb 2000Osiris Therapeutics, Inc.Vitro maintenance of hematopoietic stem cellsUS605712323 Dic 19922 May 2000British Biotech Pharmaceuticals LimitedStem cell inhibiting proteinsUS605996820 Ene 19989 May 2000Baxter International Inc.Systems for processing and storing placenta/umbilical cord bloodUS607770824 Sep 199820 Jun 2000Collins; Paul C.Method of determining progenitor cell content of a hematopoietic cell cultureUS608711319 May 199811 Jul 2000Case Western Reserve UniversityMonoclonal antibodies for human mesenchymal stem cellsUS609353119 Jun 199825 Jul 2000Neurospheres Holdings Ltd.Generation of hematopoietic cells from multipotent neural stem cellsUS611073922 Feb 199929 Ago 2000National Jewish Medical And Research CenterMethod to produce novel embryonic cell populationsUS612713527 May 19983 Oct 2000Hill; Beth LouiseMethods of obtaining compositions enriched for hematopoietic stem cells, antibodies for use therein, compositions derived therefrom and methods of use thereofUS614688821 Abr 199414 Nov 2000The University Of EdinburghMethod of enriching for mammalian stem cellsUS617433329 Dic 199816 Ene 2001Osiris Therapeutics, Inc.Biomatrix for soft tissue regeneration using mesenchymal stem cellsUS61798199 Sep 199930 Ene 2001John N. HaswellUmbilical cord blood collectionUS618403518 Nov 19986 Feb 2001California Institute Of TechnologyMethods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cellsUS619036812 May 199920 Feb 2001Children's Hospital Medical Center Of Northern CaliforniaApparatus and method for collecting blood from an umbilical cordUS62143696 May 199910 Abr 2001Morphogen Pharmaceuticals, Inc.Mesenchymal stem cells for cartilage repairUS622486015 Abr 19991 May 2001Quality Biological, Inc.Method for repopulating human bone marrow comprising culturing CD34+ cells in a serum free mediumUS622511921 May 19991 May 2001Osiris Therapeutics, Inc.Production of megakaryocytes by the use of human mesenchymal stem cellsUS622720229 Ago 19978 May 2001Maulana Azad Medical CollegeMethod of organogenesis and tissue regeneration/repair using surgical techniquesUS623188029 May 199815 May 2001Susan P. PerrineCompositions and administration of compositions for the treatment of blood disordersUS623915710 Sep 199929 May 2001Osiris Therapeutics, Inc.Inhibition of osteoclastogenesisUS624858724 Nov 199819 Jun 2001University Of Southern CailforniaMethod for promoting mesenchymal stem and lineage-specific cell proliferationUS625138324 Jun 199926 Jun 2001National Institute Of ImmunologyMethod for ex-vivo expansion of hematopoietic cellsUS62551128 Jun 19993 Jul 2001Osiris Therapeutics, Inc.Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cellsUS62615491 Jul 199817 Jul 2001Osiris Therapeutics, Inc.Human mesenchymal stem cells from peripheral bloodUS62807188 Nov 199928 Ago 2001Wisconsin Alumni Reasearch FoundationHematopoietic differentiation of human pluripotent embryonic stem cellsUS62810121 May 200028 Ago 2001Osiris Therapeutics, Inc.Method of preparing suppressor T cells with allogeneic mesenchymal stem cellsUS63003143 May 19999 Oct 2001Point Therapeutics, Inc.Hematopoietic stimulationUS63065751 Dic 199523 Oct 2001Stemcell Technologies, Inc.Methods for preparing enriched human hematopoietic cell preparationsUS631295014 Sep 19996 Nov 2001Terumo Kabushiki KaishaApparatus and method for isolating and recovering cellsUS632278426 Oct 199827 Nov 2001Osiris Therapeutics, Inc.Adipogenic differentiation of human mesenchymal stem cellsUS632601925 Jul 20004 Dic 2001Scheffer C. G. TsengGrafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeriesUS632619811 Feb 19974 Dic 2001Regents Of The University Of MichiganMethods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cellsUS63287653 Dic 199811 Dic 2001Gore Enterprise Holdings, Inc.Methods and articles for regenerating living tissueUS632896012 Mar 199911 Dic 2001Osiris Therapeutics, Inc.Mesenchymal stem cells for prevention and treatment of immune responses in transplantationUS633519523 Ene 19981 Ene 2002Maret CorporationMethod for promoting hematopoietic and mesenchymal cell proliferation and differentiationUS633738715 Nov 19968 Ene 2002Asahi Kasei Kabushiki KaishaDifferentiation-suppressive polypeptideUS633894212 Abr 199915 Ene 2002T. Breeders, Inc.Selective expansion of target cell populationsUS635523912 Mar 199912 Mar 2002Osiris Therapeutics, Inc.Uses for non-autologous mesenchymal stem cellsUS636863626 Oct 19999 Abr 2002Osiris Therapeutics, Inc.Mesenchymal stem cells for prevention and treatment of immune responses in transplantationUS63799531 Dic 199930 Abr 2002Osiris Therapeutics, Inc.Ligands that modulate differentiation of mesenchymal stem cellsUS638736728 May 199914 May 2002Osiris Therapeutics, Inc.Human mesenchymal stem cellsUS638736914 Jul 199814 May 2002Osiris Therapeutics, Inc.Cardiac muscle regeneration using mesenchymal stem cellsUS646164516 May 19908 Oct 2002Pharmastem Therapeutics, Inc.Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the bloodUS649787524 Abr 199724 Dic 2002Case Western Reserve UniversityMultilayer skin or dermal equivalent having a layer containing mesenchymal stem cellsUS6528245 *7 May 19994 Mar 2003University Of South FloridaBone marrow cells as a source of neurons for brain and spinal cord repairUS654102413 Mar 19981 Abr 2003Osiris Therapeutics, Inc.Regeneration and augmentation of bone using mesenchymal stem cellsUS668593612 Oct 19993 Feb 2004Osiris Therapeutics, Inc.Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantationUS670986428 Mar 200023 Mar 2004Osiris Therapeutics, Inc.Adipogenic differentiation of human mesenchymal stem cellsUS679726912 Mar 199928 Sep 2004Osiris Therapeutics, Inc.Mesenchymal stem cells as immunosuppressantsUS683537713 May 199828 Dic 2004Osiris Therapeutics, Inc.Osteoarthritis cartilage regenerationUS686390026 Jun 20028 Mar 2005Osiris Therapeutics, Inc.Regeneration and augmentation of bone using mesenchymal stem cellsUS687543013 Nov 20015 Abr 2005Osiris Therapeutics, Inc.Mesenchymal stem cells for prevention and treatment of immune responses in transplantationUS702966614 Ene 200218 Abr 2006Osiris Therapeutics, Inc.Uses for non-autologous mesenchymal stem cellsUS70451485 Dic 200116 May 2006Anthrogenesis CorporationMethod of collecting placental stem cellsUS724475928 Jul 200417 Jul 2007Celgene CorporationIsoindoline compounds and methods of making and using the sameUS725587912 Ago 200314 Ago 2007Anthrogenesis CorporationPost-partum mammalian placenta, its use and placental stem cells therefromUS731190413 Feb 200225 Dic 2007Anthrogenesis CorporationTissue matrices comprising placental stem cells, and methods of making the sameUS7311905 *13 Feb 200325 Dic 2007Anthrogenesis CorporationEmbryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cellsUS7468276 *22 Jun 200423 Dic 2008Anthrogenesis CorporationPlacental stem cellsUS763814121 Jul 200529 Dic 2009Anthrogenesis CorporationIsolated placental perfusate and placental cells isolated therefromUS764209124 Feb 20065 Ene 2010Jau-Nan LeeHuman trophoblast stem cells and use thereofUS768280313 Oct 200623 Mar 2010Anthrogenesis CorporationImmunomodulation using placental stem cellsUS7700090 *28 Dic 200620 Abr 2010Anthrogenesis CorporationCo-culture of placental stem cells and stem cells from a second sourceUS787527222 Dic 200525 Ene 2011Ethicon, IncorporatedTreatment of stroke and other acute neuraldegenerative disorders using postpartum derived cellsUS787527322 Dic 200525 Ene 2011Ethicon, IncorporatedTreatment of Parkinson's disease and related disorders using postpartum derived cellsUS79098065 Dic 200722 Mar 2011Anthrogenesis CorporationCord blood and placenta collection kitUS791477929 Oct 200729 Mar 2011Anthrogenesis CorporationTissue matrices comprising placental stem cells, and methods of making the sameUS200100055919 Feb 200128 Jun 2001Osiris Therapeutics, Inc.Production of megakaryocytes by the use of human mesenchymal stem cellsUS200201022396 Jul 19981 Ago 2002Jan KoopmansMethods for storing neural cells such that they are suitable for transplantationUS200201231415 Dic 20015 Sep 2002Hariri Robert J.Method of collecting placental stem cellsUS200201323436 Mar 200219 Sep 2002Clark LumSystem and method for delivering umbilical cord-derived tissue-matched stem cells for transplantationUS2002016051013 Feb 200231 Oct 2002Hariri Robert J.Renovation and repopulation of decellularized tissues and cadaveric organs by stem cellsUS2003003217913 Feb 200213 Feb 2003Hariri Robert J.Post-partum mammalian placenta, its use and placental stem cells therefromUS2003004497730 Jul 20026 Mar 2003Norio SakuragawaHuman stem cells originated from human amniotic mesenchymal cell layerUS2003018026913 Feb 200325 Sep 2003Hariri Robert J.Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cellsUS2003023556321 Abr 200325 Dic 2003Strom Stephen C.Placental derived stem cells and uses thereofUS2003023590911 Abr 200325 Dic 2003Hariri Robert J.Modulation of stem and progenitor cell differentiation, assays, and uses thereofUS200400186174 Nov 200229 Ene 2004Shiaw-Min HwangSomatic pluripotent cellsUS2004002866030 May 200312 Feb 2004Anthrogenesis CorporationMethods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromesUS2004004837212 Ago 200311 Mar 2004Anthrogenesis CorporationPost-partum mammalian placenta, its use and placental stem cells therefromUS2004004879626 Mar 200311 Mar 2004Hariri Robert J.Collagen biofabric and methods of preparation and use thereforUS2004010745314 Feb 20023 Jun 2004Furcht Leo TMultipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereofUS2004013696725 Ago 200315 Jul 2004Kansas State University Research FoundationCultures, products and methods using stem cellsUS2004016141922 Oct 200319 Ago 2004Strom Stephen C.Placental stem cells and uses thereofUS2004017114725 Nov 20032 Sep 2004Hariri Robert J.Cytotherapeutics, cytotherapeutic units and methods for treatments using themUS2004018004014 Mar 200316 Sep 2004Phillips Catherine A.Methods and compositions for directing cells to target organsUS2004021913613 Feb 20044 Nov 2004Hariri Robert JUse of umbilical cord blood to treat individuals having a disease, disorder or conditionUS2004022935131 Jul 200318 Nov 2004Anne-Marie RodriguezStem cells from adipose tissue, and differentiated cells from said cellsUS2005001986525 Jun 200427 Ene 2005Kihm Anthony J.Cartilage and bone repair and regeneration using postpartum-derived cellsUS2005003220925 Jun 200410 Feb 2005Messina Darin J.Regeneration and repair of neural tissue using postpartum-derived cellsUS2005003749125 Jun 200417 Feb 2005Sanjay MistryRepair and regeneration of ocular tissue using postpartum-derived cellsUS2005004259513 Ago 200424 Feb 2005Martin HaasBanking of multipotent amniotic fetal stem cellsUS2005005409313 Ago 200410 Mar 2005Martin HaasMultipotent amniotic fetal stem cellsUS2005005409825 Jun 200410 Mar 2005Sanjay MistryPostpartum cells derived from umbilical cord tissue, and methods of making and using the sameUS2005005862925 Jun 200417 Mar 2005Harmon Alexander M.Soft tissue repair and regeneration using postpartum-derived cellsUS2005005863025 Jun 200417 Mar 2005Harris Ian RossPostpartum-derived cells for use in treatment of disease of the heart and circulatory systemUS2005005863125 Jun 200417 Mar 2005Kihm Anthony J.Postpartum cells derived from placental tissue, and methods of making and using the sameUS2005007443520 Dic 20027 Abr 2005Robert CasperCellular compositions and methods of making and using themUS200500855437 Dic 200421 Abr 2005Synthes UsaMethods of treating bone or cartilage conditions by the administration of creatineUS2005008951317 Ago 200428 Abr 2005Norio SakuragawaSide population cells originated from human amnion and their usesUS2005011210421 Oct 200326 May 2005Pittenger Mark F.Cardiac muscle regeneration using mesenchymal stem cellsUS2005011871511 Abr 20032 Jun 2005Hariri Robert J.Modulation of stem and progenitor cell differentiation, assays, and uses thereofUS2005012400315 Nov 20029 Jun 2005Anthony AtalaMethods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereofUS200501434202 Dic 200430 Jun 2005Moutouh-De Parseval LaureMethods and compositions for the treatment and management of hemoglobinopathy and anemiaUS2005014803414 Abr 20037 Jul 2005Hariri Robert J.Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compoundsUS200501480748 Oct 20047 Jul 2005Davies John E.Progenitor cells from wharton's jelly of human umbilical cordUS2005017613911 Ene 200511 Ago 2005Yao-Chang ChenPlacental stem cell and methods thereofUS2005018150221 Mar 200518 Ago 2005Athersys, Inc.Multipotent adult stem cells and methods for isolationUS2005018618210 Nov 200425 Ago 2005Theresa DeisherMethods of using G-CSF mobilized C-Kit+ cells in the production of embryoid body-like cell clusters for tissue repair and in the treatment of cardiac myopathyUS2005023345210 Feb 200520 Oct 2005Neuronyx, Inc.Cell populations which co-express CD49c and CD90US2005023989715 Mar 200527 Oct 2005Pittenger Mark FMesenchymal stem cells and uses thereforUS2005026639114 Ene 20051 Dic 2005Bennett Brydon LMethods for preserving tissueUS2005027214821 Jul 20058 Dic 2005Hariri Robert JMethod of collecting placental stem cellsUS2005027679222 Mar 200515 Dic 2005Kaminski Joseph KSystems and methods for providing a stem cell bankUS2005028227224 Sep 200422 Dic 2005The Robarts Research InstituteUsing undifferentiated embryonic stem cells to control the immune systemUS2005028384421 Mar 200522 Dic 2005Furcht Leo TMultipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereofUS2006000845013 Jun 200512 Ene 2006Verfaillie Catherine MUse of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failureUS2006007899315 Ago 200513 Abr 2006Cellresearch Corporation Pte LtdIsolation, cultivation and uses of stem/progenitor cellsUS2006015381622 Dic 200513 Jul 2006Laura BrownSoft tissue repair and regeneration using postpartum-derived cells and cell productsUS2006015381729 Dic 200513 Jul 2006Ethicon, IncorporatedCartilage and bone repair and regeneration using postpartum-derived cellsUS2006015381829 Dic 200513 Jul 2006Ethicon, IncorporatedCartilage and bone repair and regeneration using postpartum-derived cellsUS2006015436622 Dic 200513 Jul 2006Laura BrownTreatment of osteochondral diseases using postpartum-derived cells and products thereofUS2006015436729 Dic 200513 Jul 2006Ethicon, IncorporatedCartilage and bone repair and regeneration using postpartum-derived cellsUS200601663618 Dic 200527 Jul 2006Agnieszka SeydaPostpartum cells derived from placental tissue, and methods of making, culturing, and using the sameUS200601719308 Dic 20053 Ago 2006Agnieszka SeydaPostpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the sameUS2006018898330 Dic 200524 Ago 2006Ethicon IncorporatedPostpartum-derived cells for use in treatment of disease of the heart and circulatory systemUS2006022263429 Mar 20065 Oct 2006Clarke Diana LAmnion-derived cell compositions, methods of making and uses thereofUS2006023376522 Dic 200519 Oct 2006Ethicon, IncorporatedTreatment of stroke and other acute neuraldegenerative disorders using postpartum derived cellsUS2006023376622 Dic 200519 Oct 2006Messina Darin JTreatment of Parkinson's disease and related disorders using postpartum derived cellsUS2006023437623 Dic 200519 Oct 2006Ethicon IncorporatedRepair and regeneration of ocular tissue using postpartum-derived cellsUS200602633379 Nov 200523 Nov 2006Richard MaziarzImmunomodulatory properties of multipotent adult progenitor cells and uses thereofUS2006028117825 Ago 200614 Dic 2006Norio SakuragawaHuman stem cells originating from human amniotic mesenchymal cell layerUS2007004195413 Jul 200622 Feb 2007Ichim Thomas ECompositions of placentally-derived stem cells for the treatment of cancerUS200700538886 Nov 20068 Mar 2007Hariri Robert JUse of umbilical cord blood to treat individuals having a disease, disorder or conditionUS200700924973 Nov 200626 Abr 2007Hariri Robert JCytotherapeutics, cytotherapeutic units and methods for treatments using themUS2007013421013 Oct 200614 Jun 2007Mohammad HeidaranProduction of oligodendrocytes from placenta-derived stem cellsUS2007019003413 Oct 200616 Ago 2007Casper PaludanImmunomodulation using placental stem cellsUS2007019004228 Dic 200616 Ago 2007Edinger James WComposition for collecting and preserving placental stem cells and methods of using the compositionUS2007027536228 Dic 200629 Nov 2007James EdingerPlacental stem cell populationsUS2007029239928 Dic 200620 Dic 2007Mohammad HeidaranCo-culture of placental stem cells and stem cells from a second sourceUS2007029291028 Dic 200620 Dic 2007Mohammad HeidaranCo-culture of placental stem cells and stem cells from a second sourceUS2008003240128 Dic 20067 Feb 2008James EdingerPlacental stem cell populationsUS2008013141031 Oct 20075 Jun 2008Hariri Robert JPlacental stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cellsUS2008013196629 Oct 20075 Jun 2008Hariri Robert JRenovation and repopulation of decellularized tissues and cadaveric organs by stem cellsUS200801526243 Ago 200726 Jun 2008Casper PaludanTumor suppression using placental stem cellsUS200901264828 Oct 200821 May 2009Avair, LlcBreathing gas supply visual broadcast apparatusUS200902264062 Mar 200910 Sep 2009Hariri Robert JModulation of stem and progenitor cell differentiation, assays, and uses thereofUS2009025271029 Sep 20088 Oct 2009Celgene Cellular TherapeuticsTumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cellsUS2010004721320 Ago 200925 Feb 2010Andy ZeitlinCell composition and methods of making the sameUS2010004721424 Ago 200925 Feb 2010Abramson Sascha DMethods and Compositions for Treatment of Bone Defects with Placental Cell PopulationsUS2010004735120 Ago 200925 Feb 2010Andy ZeitlinTreatment of stroke using isolated placental cellsUS2010012001513 Nov 200913 May 2010Hariri Robert JMethod of collecting placental stem cellsUS2010012456919 Nov 200920 May 2010Abbot StewartAmnion derived adherent cellsUS2010014331223 Nov 200910 Jun 2010Hariri Robert JTreatment of diseases, disorders or conditions of the lung using placental cellsUS2010018357114 Ene 201022 Jul 2010Anthrogenesis CorporationTreatment of multiple sclerosis using placental stem cellsUS2010026084724 Jun 201014 Oct 2010Anthrogenesis CorporationTissue matrices comprising placental stem cellsUS2010029167929 Jul 201018 Nov 2010Anthrogenesis CorporationComposition for collecting and preserving placental stem cells and methods of using the compositionUS2010029768930 Jul 201025 Nov 2010Anthrogenesis CorporationPlacental stem cell populationsUS201003234463 Jun 201023 Dic 2010Jill Renee BarnettMethod of collecting placental cellsUS201100033871 Jul 20106 Ene 2011Abbot StewartMethod of producing erythrocytes without feeder cellsCN1548529A9 May 200324 Nov 2004中国人民解放军军事医学科学院基础医Separation method of buffering stem cell in human placentaEP0333328B117 Feb 19898 Dic 1993Genethics LimitedClinical developments using amniotic cellsJP2003235549A Título no disponibleJP2005151907A Título no disponibleWO1990011354A119 Mar 19904 Oct 1990Institut PasteurProcess for the specific replacement of a copy of a gene present in the receiver genome via the integration of a geneWO1991001140A125 Jul 19907 Feb 1991Cell Genesys, Inc.Homologous recombination for universal donor cells and chimeric mammalian hostsWO1991006667A16 Nov 199016 May 1991Cell Genesys, Inc.Production of proteins using homologous recombinationWO1993004169A120 Ago 19924 Mar 1993Genpharm International, Inc.Gene targeting in animal cells using isogenic dna constructsWO1995022611A221 Feb 199524 Ago 1995The Regents Of The University Of MichiganMethods and compositions for stimulating bone cellsWO1995022611A321 Feb 19958 Feb 1996Univ MichiganMethods and compositions for stimulating bone cellsWO1996039101A16 Jun 199612 Dic 1996Advanced Tissue Sciences, Inc.Compositions and methods for naturally secreted extracellular matrixWO1998037903A125 Feb 19983 Sep 1998Tseng Scheffer C GGrafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeriesWO1999064566A28 Jun 199916 Dic 1999Osiris Therapeutics, Inc.In vitro maintenance of hematopoietic stem cellsWO2000017325A123 Sep 199930 Mar 2000Mount Sinai HospitalTrophoblast cell preparationsWO2000027999A212 Nov 199918 May 2000Cell Science Therapeutics, Inc.Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devicesWO2000027999A312 Nov 19993 Ago 2000Cytomatrix LlcLymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devicesWO2000073421A21 Jun 20007 Dic 2000Lifebank Services, L.L.C.Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cellsWO2000073421A31 Jun 200026 Abr 2001Lifebank Services L L CMethods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cellsWO2001093909A24 Jun 200113 Dic 2001Glaxo Group LimitedCancer treatment composition containing an anti-neoplastic agent and a pde4 inhibitorWO2001093909A34 Jun 20015 Dic 2002Stephen Thomas DavisCancer treatment composition containing an anti-neoplastic agent and a pde4 inhibitorWO2002046373A15 Dic 200113 Jun 2002Hariri Robert JMethod of collecting placental stem cellsWO2002063962A Título no disponibleWO2005105992A119 Abr 200510 Nov 2005New York Eye & Ear InfirmaryChondrocyte culture formulations* Citada por examinadorOtras citasReferencia1Abbott, 2003, ABCG2 (BCRP)expression in normal and malignant hematopoietic cells, Hematol Oncol 21:115-130.2Abe, "Therapeutic Potential of Neurotrophic Factors and Neural Stem Cells Against lschemic Brain Injury," Journal of Cerebral Blood Flow and Metabolism, Raven Press, Ltd., New York, 20(10): 1393-1408 (2000).3Abkowitz, 2002, Can human hematopoietic stem cells become skin, gut, or liver cells? N Engl J Med. 346(10):770-2.4Addison et al., "Metabolism of Prednisolone by the Isolated Perfused Human Placental Lobule", J. Ster. Biochem Mol. Biol., vol. 39 No. 1, pp. 83-90 (1991).5Advisory Action dated Aug. 17, 2009 in U.S. Appl. No. 10/721,444.6Advisory Action dated Feb. 6, 2006 in U.S. Appl. No. 10/721,144.7Advisory Action dated Jul. 12, 2004 in U.S. Appl. No. 10/076,180.8Advisory Action dated Jun. 6, 2006 in U.S. Appl. No. 10/779,369.9Advisory Action dated Oct. 7, 2009 in U.S. Appl. No. 10/721,144.10Ballin, et al., "Autologous Umbilical Cord Blood Transfusion," Arch. Dis. Child Fetal Neonatal. Ed. 73(3):F181-F183 (1995).11 *Barlow et al. Stem Cell Dev 2008;17:1095-1108.12Barry, 1994, "Where do all the placentas go?" Canadian Journal of Infection Control 9(1):8-10.13Belvedere et al., 2000, "Increased blood volume and CD34(+)CD36(-) progenitor cell recovery using a novel umbilical cord blood collection system," Stem Cells 18(4):245-251.14Belvedere et al., 2000, "Increased blood volume and CD34(+)CD36(−) progenitor cell recovery using a novel umbilical cord blood collection system," Stem Cells 18(4):245-251.15Bertolini et al., 1994, Retrovirus-mediated transfer of the multidrug resistance gene into human haemopoietic progenitor cells. Haemolotol 88:318-324.16Caplan, Clin Plast Surg 21(3):429-435 (1994).17CD34, Medline Mesh Database, 2004.18Chen et al. "Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats" Stroke 32:2682-2688 (2001).19Cole et al., 1985, EBV-Hydrudoma techique and its application to human lung cancer. In Monoclonal Antibodies and Cancer Therapy, Alan R. Liss, Inc., 77-96.20Conget et al. "Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells" Journal of Cellular Physiology 181:67-73 (1999).21Contractor et al., 1984, "A comparison of the effects of different perfusion regimens on the structure of the isolated human placental lobule," Cell Tissue Res. 237:609-617.22Cord Blood Stem Cell, Mesh Term Database, 2003.23Cote et al., 1983, Generation of human monoclonal antibodies reactive with cellular antigens. Proc Natl Acad Sci U S A. 80(7):2026-30.24Damjanov et al., 1993, Retinoic acid-induced differentiation of the developmentally plutipotent human germ cell tumor-derived cell line, NCCIT. Lab Invest. 68(2):220-32.25 *Deans et al. Exp Hematol 2000;28: 875-84.26DeLoia et al, 1998, Effects of methotrexate on trophoblast proliferation and local immune responses.Hum Reprod. 13(4):1063-9.27Denison et al. "Cytokine secretion by human fetal membranes, decidua and placenta at term" Human Reproduction 13(12):3560-3565 (1998).28Dorrel, 2000, Expansion of human cord blood CD34+CD38- cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulation cell (SRC) frequency: dissociation of SRC phenotype and function, Blood, 95(1):102-110.29Dorrel, 2000, Expansion of human cord blood CD34+CD38− cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulation cell (SRC) frequency: dissociation of SRC phenotype and function, Blood, 95(1):102-110.30Douay et al, 1995. Characterization of late and early hematopoietic progenitor/stem cell sensitivity to mafosfamide. Bone Marrow Transplant. 15(5):769-75.31Dushnik-Levinson et al. 1995, Embryogenesis in vitro: study of differentiation of embryonic stem cells.Biol Neonate. 67(2):77-83.32Elebalal et al., 2000, "Postpartum umbilical cord blood collection for transplantation: a comparison of three methods," Am. J. of Obstetrics & Gyn. 182(1 Pt 1):227-232.33Emerson, 1996, Ex vivo expansion of hematopoietic precursors, progenitors and stem cells: the next generation of cellular therapeutics, Blood, 87:3072-3088.34Ende, "Pooled umbilical cord blood as a possible universal donor for marrow reconstitution and use in nuclear accidents," Life Sciences 69:1531-1539 (2001).35Erices et al., "Mesenchymal progenitor cells in human umbilical cord blood," Br. J. Haematol. 109(1):235-242 (2000).36Extended European Search Report dated Mar. 11, 2011 for EP Application No. 10183435.6-2401 (specification corresponding to U.S. Patent No. 7,045,148).37Extended European Search Report dated Mar. 22, 2011 for EP Application No. 10183252.5-2401 (specification corresponding to U.S. Patent No. 7,311,904).38Extended European Search Report dated Mar. 25, 2011 for EP Application No. 10182195.7-2401 (specification corresponding to U.S. Patent No. 7,468,276).39Extended European Search Report dated Mar. 25, 2011 for EP Application No. 10182243.5-2401 (specification corresponding to U.S. Patent No. 7,468,276).40Extended European Search Report dated Mar. 25, 2011 for EP Application No. 10182362.3-2401 (specification corresponding to U.S. Patent No. 7,468,276).41Extended European Search Report dated Mar. 25, 2011 for EP Application No. 10182485.2-2401 (specification corresponding to U.S. Patent No. 7,468,276).42Extended European Search Report dated Mar. 25, 2011 for EP Application No. 10183301.0-2401 (specification corresponding to U.S. Patent No. 7,311,904).43Extended European Search Report dated Mar. 28, 2011 for EP Application No. 10182433.2-2401 (specification corresponding to U.S. Patent No. 7,468,276).44Extended European Search Report dated Mar. 3, 2011 for EP Application No. 10183378.8-2401 (specification corresponding to U.S. Patent No. 7,045,148).45Extended European Search Report dated Mar. 30, 2011 for EP Application No. 10182303.7-2401 (specification corresponding to U.S. Patent No. 7,468,276).46Extended Search Report mailed Mar. 25, 2011 in Application No. EP 10182243.5-2401.47Fasouliotis et al., "Human umbilical cord blood banking and transplantation: a state of the art," Eur. J. Obstet. Gynecol. Reprod. Biol. 90(1):13-25 (2000).48Fassas, et al., "Autologous Stem Cell Transplantation in Progressive Multiple Sclerosis—An Interim Analysis of Efficacy," J. Clin, Immunol., 20(1):24-30 (2000).49Final Office Action dated Aug. 4, 2010 in U.S. Appl. No. 11/592,544.50Final Office Action dated Feb. 1, 2011 in U.S. Appl. No. 11/982,291.51Final Office Action dated Feb. 7, 2011 in U.S. Appl. No. 12/030,161.52Final Office Action dated Jan. 28, 2011 in U.S. Appl. No. 11/982,007.53Final Office Action dated May 20, 2010 in U.S. Appl. No. 11/648,804.54Final Office Action dated Nov. 3, 2010 in U.S. Appl. No. 11/982,211.55Final Office Action dated Nov. 3, 2010 in U.S. Appl. No. 12/030,170.56Final Office Action dated Nov. 7, 2005 in U.S. Appl. No. 10/779,369.57Final Office Action dated Oct. 27, 2009 in U.S. Appl. No. 11/648,813.58Final Office Action dated Sep. 14, 2010 in U.S. Appl. No. 10/721,144.59Genbacev et al. 1995,Maternal smoking inhibits early human cytotrophoblast differentiation. Reprod Toxicol. 9(3):245-55.60Hatzopoulos et al. 1998, Isolation and characterization of endothelial progenitor cells from mouse embryos.Development. 125(8):1457-68.61Himori, et al , 1984, Chemotherapeutic susceptibility of human bone marrow progenitor cells and human myelogenous leukemia cells (HL-60) in co-culture: preliminary report. Int J Cell Cloning. 2(4):254-62.62Hirashima et al. 1999, Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis. Blood. 93(4):1253-63.63Hsieh et al. "Effects of glucose on placental hormones in the human term placenta in vitro" J. Formos. Med. Assoc. 96:309-313 (1997).64Hume et al., "Red Blood Cell Transfusions For Preterm Infants: The Role of Evidence-Based Medicine," Seminars in Perinatology, W.B. Saunders, GB 21(1):14-15 (1997).65Jaroscak et al. "Preliminary characterization of the surface staining of placental derived adherent cells: a potential new source of stroma for umbilical cord blood (UCB) expansion," Blood 96(11, Pt 2) (2000).66Kawata et al., "Transcriptional Control of HLA-A,B,C Antigen in Human Placental Cytotrophoblast Isolated Using Trophoblast- and HLA-Specific Monoclonal Antibodies and the Fluorescence-Activated Cell Sorter," J. Exp. Med. 160(3):633-51 (1984).67Keown et al., 1990, Methods for introducing DNA into mammalian cells. Methods Enzymol. 185:527-37.68Korbling et al., 2002, Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med. 346(10):738-46.69Kozbor et al., 1983, The productrion of monoclonal antibodies from human lymphocytes. Immunology Today 4, 72-79.70Kurtzberg et al., 1996, Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 335:157-166.71Larsson et al., 2002, Angiogenesis. 5:107-110.72Leonard et al., 2003, Oncologist. 8:411-424.73Lowy et al. 1980, Isolation of transforming DNA: cloning the hamster aprt gene. Cell. 22(3):817-23.74Ma et al., 1999, Development of an in vitro human placenta model by the cultivation of human ytophoblasts in a fiber-based bioreactor system, tissue Engineering 5:91-102.75MacLaren et al., 1992, Inter- and Intraspecific Placentae in Sheep, Goats and Sheep-Goat Chimaeras, J Comp Pathol, 106:279-297.76Madri et al., 1983, Capillary endothelial cell cultures: phenotypic modulation by matrix components, J Cell Biol 97:153-165.77Malek et al. "Lack of transport of erythropoietin across the human placenta as studied by an in vitro perfusion system," European Journal of Physiology 427:157-161 (1994).78Marmont, "New Horizons in the Treatment of Autoimmune Diseases: Immunoablation and Stem Cell Transplantation," Ann. Rev. Medicine 51:115-134 (2000).79Melchner, et al., 1985, Human placental conditioned medium reverses apparent commitment to differentiation of human promyelocytic leukemia cells (HL60) Blood. 66(6):1469-72.80Minguell et al., Exp Biol Med 226:507-520 (2001).81Moore et al., 1997, "A simple perfusion technique for isolation of maternal intervillous blood mononuclear cells from human placentae," J. Immunol. Methods 209(1):93-104.82Mühlemann et al., 1995, Placenta. 16:367-373.83Mulligan and Berg, 1981 Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase Proc Natl Acad Sci U S A. 78(4):2072-6.84Myllynen, dissertation, University of Oulu, 2003.85Nadkami et al. 1984, Effect of retinoic acid on bone-marrow committed stem cells (CFU-c) from chronic myeloid leukemia patients. Tumori. 70(6):503-5.86Non Final Office Action dated Dec. 15, 2009 in U.S. Appl. No. 12/030,170.87Non Final Office Action dated Feb. 1, 2011 in U.S. Appl. No. 10/721,144.88Non Final Office Action dated Feb. 4, 2009 in U.S. Appl. No. 11/592,544.89Non Final Office Action dated Jul. 15, 2010 in U.S. Appl. No. 11/982,291.90Non Final Office Action dated Jul. 19, 2010 in U.S. Appl. No. 11/982,007.91Non Final Office Action dated Jul. 9, 2010 in U.S. Appl. No. 12/259,259.92Non Final Office Action dated Jun. 4, 2010 in U.S. Appl. No. 12/030,170.93Non Final Office Action dated Jun. 7, 2010 in U.S. Appl. No. 11/648,813.94Non Final Office Action dated Jun. 7, 2010 in U.S. Appl. No. 11/980,012.95Non Final Office Action dated May 24, 2010 in U.S. Appl. No. 11/982,211.96Non Final Office Action dated May 26, 2010 in U.S. Appl. No. 12/030,161.97Non-Final Office Action dated Oct. 21, 2009 in U.S. Appl. No. 11/648,804.98Notice of Allowance dated Aug. 12, 2009 in U.S. Appl. No. 11/187,400.99Notice of Allowance dated Jan. 10, 2011 in U.S. Appl. No. 11/648,813.100Notice of Allowance dated Nov. 29, 2010 in U.S. Appl. No. 11/980,012.101Notice of Allowance in U.S. Appl. No. 10/004,942, now US Patent No. 7,045,148, Sep. 15, 2005.102Notice of Allowance in U.S. Appl. No. 10/074,976, now US Patent No. 7,311,904, Aug. 15, 2007.103Notice of Allowance in U.S. Appl. No. 10/366,671, now US Patent No. 7,311,905, Sep. 10, 2007.104Notice of Allowance in U.S. Appl. No. 10/640,428, now US Patent No. 7,255,879, May 21, 2007.105Office Action dated Apr. 20, 2007 in U.S. Appl. No. 11/187,400.106Office Action dated Aug. 28, 2003 in U.S. Appl. No. 10/076,180.107Office Action dated Dec. 16, 2004 in U.S. Appl. No. 10/004,942, now US Patent No. 7,045,148.108Office Action dated Dec. 28, 2006 in U.S. Appl. No. 10/721,144.109Office Action dated Dec. 5, 2003 in U.S. Appl. No. 10/004,942, now US Patent No. 7,045,148.110Office Action dated Feb. 5, 2008 in U.S. Appl. No. 10/721,144.111Office Action dated Jan. 11, 2006 in U.S. Appl. No. 10/721,144.112Office Action dated Jan. 19, 2006 in U.S. Appl. No. 10/640,428, now US Patent No. 7,255,879.113Office Action dated Jan. 26, 2009 in U.S. Appl. No. 11/648,813.114Office Action dated Jan. 29, 2006 in U.S. Appl. No. 10/366,671, now US Patent No. 7,311,905.115Office Action dated Jan. 4, 2008 in U.S. Appl. No. 11/187,400.116Office Action dated Jan. 5, 2006 in U.S. Appl. No. 10/074,976, now US Patent No. 7,311,904.117Office Action dated Jun. 14, 2006 in U.S. Appl. No. 10/721,144.118Office Action dated Jun. 15, 2004 in U.S. Appl. No. 10/004,942, now US Patent No. 7,045,148.119Office Action dated Jun. 20, 2005 in U.S. Appl. No. 10/004,942, now US Patent No. 7,045,148.120Office Action dated Jun. 20, 2005 in U.S. Appl. No. 10/076,180.121Office Action dated Jun. 27, 2007 in U.S. Appl. No. 10/721,144.122Office Action dated Mar. 18, 2004 in U.S. Appl. No. 10/076,180.123Office Action dated Mar. 18, 2010 in U.S. Appl. No. 10/721,144.124Office Action dated Mar. 27 2007 in U.S. Appl. No. 10/074,976, now US Patent No. 7,311,904.125Office Action dated Mar. 29, 2005 in U.S. Appl. No. 10/779,369.126Office Action dated May 14, 2007 in U.S. Appl. No. 10/366,671, now US Patent No. 7,311,905.127Office Action dated May 22, 2008 in U.S. Appl. No. 11/187,400.128Office Action dated May 7, 2003 in U.S. Appl. No. 10/004,942, now US Patent No. 7,045,148.129Office Action dated Oct. 10, 2006 in U.S. Appl. No. 10/366,671, now US Patent No. 7,311,905.130Office Action dated Oct. 18, 2006 in U.S. Appl. No. 10/640,428, now US Patent No. 7,255,879.131Office Action dated Oct. 20, 2004 in U.S. Appl. No. 10/076,180.132Office Action dated Oct. 4, 2005 in U.S. Appl. No. 10/721,144.133Office Action dated Sep. 20, 2006 in U.S. Appl. No. 10/074,976, now US Patent No. 7,311,904.134Office Action dated Sep. 23, 2004 in U.S. Appl. No. 10/074,976, now US Patent No. 7,311,904.135O'Hare et al. 1981, Transformation of mouse fibroblasts to methotrexate resistance by a recombinant plasmid expressing a prokaryotic dihydrofolate reductase. Proc Natl Acad Sci U S A. 78(3):1527-31.136Oppenheim et al., 2001, Evidence against humoral immune attach as the cause of sheep-goat interspecies and hybrid pregnancy failure in the doe, Theriogenology 55:1567-1581.137Ordi et al., 1998, Am J Surg Pathol. 8:1006-1011.138Papaioannou et al., Stem Cells Handbook:19-31 (2004).139Parolini et al. "Concise review: Isolation and characterization of cells from human term placenta: Outcome of the first international workshop on placenta derived stem cells" Stem Cells 26:300-311 (2008).140Pittenger, M. F., et al. "Multilineage Potential of Adult Human Mesenchymal Stem Cells," Science (1999) U.S. vol. 284, No. 5411, pp. 143-147.141Placenta, Britannica Online, 2003.142Ponticiello et al. "Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy" Journal of Biomedical Materials Research 52:246-255 (2000).143Ray et al., 1997, CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family. J Biol Chem. Jul. 25, 1997;272(30):18702-8.144Reubinoff, "Neural Progenitors from Human Embryonic Stem Cells," Nature Biotech. 19(12):1134-1140 (2001).145Reyes et al. 2002, Origin of endothelial progenitors in human postnatal bone marrow.J Clin Invest. 109(3):337-46.146Reyes et al., "Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells," Blood 98(9):2615-2625 (2001).147Santerre et al., 1984, Expression of prokaryotic genes for hygromycin B and G418 resistance as dominant-selection markers in mouse L cells. Gene. 30(1-3):147-56.148Semenov et al. "Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of sternness after isolation" American Journal of Obstetrics & Gynecolocy 202:193.e1-13 (2010).149Shamblott, et al., 1998, Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci U S A. 95(23):13726-31.150Slager 1993, Transforming growth factor-beta in the early mouse embryo: implications for the regulation of muscle formation and implantation. Dev Genet. 14(3):212-24.151Smithies et al. 1985, Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature. 317(6034):230-4.152Srour, 1999, Ex vivo expansion of hematopoietic stem and progenitor cells. Are we there yet? The Journal of Hematotherapy 8:93-102.153Stromberg et al., 1980, Methods in cell biology, Chapter 10: The human Placenta in cell and organ culture, 21:227-252.154Szybalska and Szybalska, 1962, Genetics of human cell lines IV: DNA-mediated heritable transformation of biochemical trait. PNAS 48: 2026-2034.155Thomas and Capecchi, 1987, Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell. 51(3):503-12.156Thomson et al., 1998, Embryonic stem cell lines derived from human blastocysts. Science. 282 (5391): 1145-7.157Totipotent Stem Cells, Medline, Mesh Database, 2004.158Totipotent Stem Cells, Stem Cells Information Center Online, 2004.159Tremblay et al., 2001, Diethylstilbestrol regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERR beta. Genes Dev. 15(7):833-8.160Turner et al., 1992, "A modified harvest technique for cord blood hematopoietic stem cells," Bone Marrow Transplantation 10:89-91.161U.S. Appl. No. 11/580,588, filed Oct. 13, 2006, Paludan.162U.S. Appl. No. 11/580,625, filed Oct. 13, 2006, Heidaran.163U.S. Appl. No. 11/648,802, filed Dec. 28, 2006, Heidaran.164U.S. Appl. No. 11/648,804, filed Dec. 28, 2006, Edinger.165U.S. Appl. No. 11/648,812, filed Dec. 28, 2006, Heidaran.166U.S. Appl. No. 11/648,813, filed Dec. 28, 2006, Edinger.167U.S. Appl. No. 11/648,824, filed Dec. 28, 2006, Heidaran.168U.S. Appl. No. 11/877,475, filed Oct. 23, 2007, Edinger et al.169U.S. Appl. No. 11/982,211, filed Oct. 31, 2007, Heidaran et al.170U.S. Appl. No. 11/982,291, filed Oct. 31, 2007, Edinger et al.171U.S. Appl. No. 12/030,161, filed Feb. 12, 2008, Edinger et al.172U.S. Appl. No. 12/030,170, filed Feb. 12, 2008, Edinger et al.173U.S. Appl. No. 12/823,063, filed Jun. 24, 2010, Hariri.174U.S. Appl. No. 12/829,326, filed Jul. 1, 2010, Abbot.175U.S. Appl. No. 12/846,765, filed Jul. 29, 2010, Edinger et al.176U.S. Appl. No. 12/848,007, filed Jul. 30, 2010, Edinger et al.177U.S. Appl. No. 13/081,415, filed Apr. 6, 2011, Abbot.178U.S. Appl. No. 13/081,422, filed Apr. 6, 2011, Edinger.179Uchimura et al. 1998, Human N-acetylglucosamine-6-O-sulfotransferase involved in the biosynthesis of 6-sulfo sislyl Lewis X: molecular cloning, chromosomal mapping, and expression in various organs and tumor cells. J Biochem (Tokyo). 124(3):670-8.180Van Bekkum, Verh Disch Ges Patol 74:19-24 (1990).181Vawda et al., "Stem Cell Therapies for Perinatal Brain Injuries", Seminars in Fetal and Neonatal Medicine, Elsevier, GB 12(4):259-272 (2007).182Viscord, 2001, Umbilical cord blood can save lives (Informational brochure), Boston: ViaCell CENTR-BRO R1 Oct. 2001.183Wang et al., 2001, "Enhanced recovery of hematopoietic progenitor and stem cells from cultivated, postpartum human placenta," Blood 98(11/1):183a Abstract No. 769.184Wigler et al. 1997, Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell. 11(1):223-32.185Woods et al., "Osomometric and permeability characteristics of human placental/umbilical cord blood CD34+ cells and their application to cryopreservation," J. Hematother. Stem Cell Res. 9(2):161-173 (2000).186Xu et al. "Feeder-free growth of undifferentiated human embryonic stem cells" Nature Biotechnology 19:971-974 (2001).187Yan et al., 2001, Retinoic acid promotes differentiation of trophoblast stem cells to a giant cell fate.Dev Biol. 235(2):422-32.188Ye et al., 2001, "Recovery of placental-derived adherent cells with mesenchymal stem cell characteristics," Blood 98(11/1):147b Abstract No. 4260.189Yen et al. "Isolation of multipotent cells from human term placenta" Stem Cells 23:3-9 (2005).190Yin et al "AC133, a novel marker for human hematopoietic stem and progenitor cells" Blood 90(12):5002-5012 (1997).191Zhao, et al., "Human Bone Marrow Stem Cells Exhibit Neural Phenotypes After Transplantation and Ameliorate Neurological Deficits with Ischemic Brain Injury in Rats," Abstract of the Annual Meeting of the Society for Neuroscience, Society of Neuroscience, Washington, DC, 26(Jan. 2002):860.01, XP001159670 (2000).192Zhao, et al., "Transplanted Human Bone Marrow-Derived Adult Stem Cells Survive and Improve Functional Outcome in a Rat Model of Cortical Ischemic Brain Injury," Experimental , Neurology, Academic Press, New York, 164(2):465-466, XP001159669 (2000).* Citada por examinador Citada por Patente citante Fecha de presentación Fecha de publicación Solicitante TítuloUS805778931 Oct 200715 Nov 2011Anthrogenesis CorporationPlacental stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cellsUS807137613 Oct 20066 Dic 2011Anthrogenesis CorporationProduction of oligodendrocytes from placenta-derived stem cellsUS820270330 Jul 201019 Jun 2012Anthrogenesis CorporationPlacental stem cell populationsUS821656614 Ene 201010 Jul 2012Anthrogenesis CorporationTreatment of multiple sclerosis using placental stem cellsUS829322330 Sep 201123 Oct 2012Anthrogenesis CorporationTreatment of organ injuries and burns using placental stem cellsUS837243717 Ago 200712 Feb 2013Mimedx Group, Inc.Placental tissue graftsUS843578824 Jun 20107 May 2013Anthrogenesis CorporationTissue matrices comprising placental stem cellsUS84607157 Ago 201211 Jun 2013Mimedx Group, Inc.Placental tissue graftsUS84607167 Ago 201211 Jun 2013Mimedx Group, Inc.Method for applying a label to a placental tissue graftUS85629736 Abr 201122 Oct 2013Anthrogenesis CorporationTreatment of sarcoidosis using placental stem cellsUS857456724 Sep 20105 Nov 2013The Brigham And Women's Hospital, Inc.Multipotent stem cells and uses thereofUS858056327 Oct 200812 Nov 2013Anthrogenesis CorporationPlacental stem cellsUS85863601 Jul 201019 Nov 2013Anthrogenesis CorporationMethod of producing erythrocytes without feeder cellsUS859188316 May 201226 Nov 2013Anthrogenesis CorporationPlacental stem cell populationsUS85976877 Ago 20123 Dic 2013Mimedx Group, Inc.Methods for determining the orientation of a tissue graftUS862342126 Jul 20137 Ene 2014Mimedx Group, Inc.Placental graftUS869121724 May 20128 Abr 2014Anthrogenesis CorporationPlacental stem cell populationsUS870949430 Jul 201329 Abr 2014Mimedx Group, Inc.Placental tissue graftsUS879631515 Mar 20135 Ago 2014Darlene E. McCordMethods for improved wound closure employing olivamine and human umbilical vein endothelial cellsUS8828376 *20 Ago 20099 Sep 2014Anthrogenesis CorporationTreatment of stroke using isolated placental cellsUS88894112 Mar 200918 Nov 2014Anthrogenesis CorporationModulation of stem and progenitor cell differentiation, assays, and uses thereofUS889525617 May 201225 Nov 2014Anthrogenesis CorporationImmunomodulation using placental stem cellsUS892696413 Jul 20116 Ene 2015Anthrogenesis CorporationMethods of generating natural killer cellsUS896931529 Dic 20113 Mar 2015Anthrogenesis CorporationEnhancement of placental stem cell potency using modulatory RNA moleculesUS898698413 Nov 200924 Mar 2015Anthrogenesis CorporationMethod of propagating cellsUS901823711 Jul 201428 Abr 2015Darlene E. McCordMethods for improved wound closure employing olivamine and endothelial cellsUS904003531 May 201226 May 2015Anthrogenesis CorporationTreatment of pain using placental stem cellsUS907889814 Feb 201414 Jul 2015Anthrogenesis CorporationPlacental stem cell populationsUS912100725 Ene 20111 Sep 2015Anthrogenesis CorporatinTreatment of bone-related cancers using placental stem cellsUS912725213 Mar 20138 Sep 2015The Brigham And Women's Hospital, Inc.Multipotent stem cells and uses thereofUS913981315 Abr 201322 Sep 2015Anthrogenesis CorporationRenovation and repopulation of decellularized tissues and cadaveric organs by stem cellsUS914455527 Nov 201329 Sep 2015Darlene E. McCordHydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibitionUS914956916 May 20116 Oct 2015Anthrogenesis CorporationTreatment of diseases or disorders using placental stem cellsUS92002536 Ago 20081 Dic 2015Anthrogenesis CorporationMethod of producing erythrocytesUS921620013 Ago 201222 Dic 2015Anthrogenesis CorporationTumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cellsUS92543026 Abr 20119 Feb 2016Anthrogenesis CorporationAngiogenesis using placental stem cellsUS925524811 Oct 20139 Feb 2016Anthrogenesis CorporationMethod of producing erythrocytes without feeder cellsUS926580011 Feb 201523 Feb 2016Mimedx Group, Inc.Placental tissue graftsUS926580124 Mar 201523 Feb 2016Mimedx Group, Inc.Placental tissue graftsUS92720059 Mar 20151 Mar 2016Mimedx Group, Inc.Placental tissue graftsUS93872836 Jun 201412 Jul 2016Anthrogenesis CorporationMethod of collecting placental stem cellsUS943364721 Mar 20146 Sep 2016Mimedx Group, Inc.Placental tissue graftsUS946320722 May 201411 Oct 2016Mimedx Group, Inc.Placental tissue graftsUS946427418 Nov 201411 Oct 2016Anthrogenesis CorporationMethods of generating natural killer cellsUS953928822 Oct 201410 Ene 2017Anthrogenesis CorporationImmunomodulation using placental stem cellsUS957283929 Dic 201421 Feb 2017Mimedx Group, Inc.Placental tissue grafts and methods of preparing and using the sameUS20070134210 *13 Oct 200614 Jun 2007Mohammad HeidaranProduction of oligodendrocytes from placenta-derived stem cellsUS20080046095 *17 Ago 200721 Feb 2008Surgical Biologics, Inc.Placental Tissue Grafts and Improved Methods of Preparing and Using the SameUS20080175824 *31 Oct 200724 Jul 2008Mohammad HeidaranCo-culture of placental stem cells and stem cells from a second sourceUS20090053805 *27 Oct 200826 Feb 2009Anthrogenesis CorporationPost-partum mammalian placenta, its use and placental stem cells therefromUS20090226406 *2 Mar 200910 Sep 2009Hariri Robert JModulation of stem and progenitor cell differentiation, assays, and uses thereofUS20100047351 *20 Ago 200925 Feb 2010Andy ZeitlinTreatment of stroke using isolated placental cellsUS20100120015 *13 Nov 200913 May 2010Hariri Robert JMethod of collecting placental stem cellsUS20100183571 *14 Ene 201022 Jul 2010Anthrogenesis CorporationTreatment of multiple sclerosis using placental stem cellsUS20110223141 *16 May 201115 Sep 2011Anthrogenesis CorporationTreatment of brain or spinal cord injury using placental stem cells* Citada por examinadorClasificaciones Clasificación de EE.UU.424/93.1, 435/325, 435/366 Clasificación internacionalA61P29/00, C12M1/34, C12N5/00, A61K35/44, A61K48/00, A61M1/02, A61P9/00, C12N5/02, A61P17/02, C12N5/0789, A61K35/28, C12N15/09, A61P7/06, A61P25/28, A61P3/00, C12N5/073, C12M3/00, A61K35/14, A61P25/00, A61P27/02, A01N63/00, A61P27/06, C12M1/36, A61K35/50, A61P25/16, A61P5/14, A61P21/00, A61P9/10, A61K35/12, C12N5/0775, A61P13/12, A61P43/00, C12M1/00, C12N15/00 Clasificación cooperativaC12N5/0605, A61M1/02, A01N1/021, C12N5/0647, C12M47/04, A61K35/50, A61K2035/124, C12M29/10, C12N2510/02, C12N2509/00, A61M2210/1458, A61M2210/1466, A61M2202/0462, C12N5/0603, C12N2533/90, A61K35/12, A61K48/00, C12N5/0668 Clasificación europeaC12N5/06B21P, A61M1/02, C12N5/06B11P, C12N5/00S, C12N5/06B2LEventos legales FechaCódigoEventoDescripción2 Jul 2010ASAssignmentOwner name: ANTHROGENESIS CORPORATION,NEW JERSEYFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HARIRI, ROBERT J.;REEL/FRAME:024634/0033Effective date: 20020218Owner name: ANTHROGENESIS CORPORATION, NEW JERSEYFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HARIRI, ROBERT J.;REEL/FRAME:024634/0033Effective date: 2002021812 Ene 2015FPAYFee paymentYear of fee payment: 4GirarImagen originalPágina principal de Google - Sitemap - Descargas en bloque de USPTO - Política de privacidad - Condiciones de Servicio - Acerca de Google Patentes - Enviar sugerenciasDatos proporcionados por IFI CLAIMS Patent Services